TriviumVet’s felycin®-CA1 granted conditional FDA approval for feline hypertrophic cardiomyopathy treatment

Discover felycin®-CA1, the first FDA-approved treatment for feline hypertrophic cardiomyopathy. Find out more.

The post TriviumVet’s felycin®-CA1 granted conditional FDA approval for feline hypertrophic cardiomyopathy treatment appeared first on Innovation News Network.